Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (311-320 of 773) with videos related to

Pageof 78
Sort By:
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significanceShaji Kumar, S Vincent Rajkumar, Robert A Kyle, et al.
Blood Cancer Journal|March 23, 2024
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysisFieke W Hoff, Rahul Banerjee, Adeel M Khan, et al.
British Journal of Haematology|November 20, 2002
Bone marrow angiogenesis in multiple myeloma: effect of therapyShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Leukemia|February 28, 2024
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-upNadine Abdallah, Thomas E Witzig, Shaji K Kumar, et al.
British Journal of Haematology|October 20, 2004
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar, Robert A Kyle, Terry M Therneau, et al.
Leukemia|April 22, 2026
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myelomaArwa Bohra, Surendra Dasari, Saurabh Zanwar, et al.
Blood Cancer Journal|December 4, 2025
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myelomaMeletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, et al.
Mayo Clinic Proceedings|March 5, 2008
Serum uric acid: novel prognostic factor in primary systemic amyloidosisShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myelomaS Vincent Rajkumar, Paul G Richardson, Martha Q Lacy, et al.
Pageof 78

Showing results (311-320 of 773) with videos related to

Sort By:
Pageof 78
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significanceShaji Kumar, S Vincent Rajkumar, Robert A Kyle, et al.
Blood Cancer Journal|March 23, 2024
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysisFieke W Hoff, Rahul Banerjee, Adeel M Khan, et al.
British Journal of Haematology|November 20, 2002
Bone marrow angiogenesis in multiple myeloma: effect of therapyShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.
Leukemia|February 28, 2024
Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-upNadine Abdallah, Thomas E Witzig, Shaji K Kumar, et al.
British Journal of Haematology|October 20, 2004
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar, Robert A Kyle, Terry M Therneau, et al.
Leukemia|April 22, 2026
Gene expression-based dissemination score predicts early spread and poor outcomes in multiple myelomaArwa Bohra, Surendra Dasari, Saurabh Zanwar, et al.
Blood Cancer Journal|December 4, 2025
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myelomaMeletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, et al.
Mayo Clinic Proceedings|March 5, 2008
Serum uric acid: novel prognostic factor in primary systemic amyloidosisShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myelomaS Vincent Rajkumar, Paul G Richardson, Martha Q Lacy, et al.
Pageof 78